Skip to main content

Peer Review reports

From: Downregulated TICAM1 is a prognostic biomarker and associated with immune tolerance of Wilms tumor patients

Original Submission
17 Apr 2022 Submitted Original manuscript
5 Jun 2022 Reviewed Reviewer Report
24 Jun 2022 Reviewed Reviewer Report
8 Jul 2022 Author responded Author comments - Fengyin Sun
Resubmission - Version 2
8 Jul 2022 Submitted Manuscript version 2
8 Jul 2022 Author responded Author comments - Fengyin Sun
Resubmission - Version 3
8 Jul 2022 Submitted Manuscript version 3
22 Jul 2022 Reviewed Reviewer Report
27 Jul 2022 Author responded Author comments - Fengyin Sun
Resubmission - Version 4
27 Jul 2022 Submitted Manuscript version 4
Publishing
29 Jul 2022 Editorially accepted
6 Aug 2022 Article published 10.1186/s12920-022-01326-5

You can find further information about peer review here.

Back to article page